Genetic factors may determine an individual's blood pressure (BP) level and risk for hypertension. This study aimed to examine the associations between genetic variants of the adrenomedullin (ADM) gene and essential hypertension, as well as BP levels, in a Chinese Han population. In this study, 2410 hypertensive patients and 2346 normal controls were recruited. Three tagging single-nucleotide polymorphisms (SNPs) based on the HapMap CHB data were selected and genotyped. No significant associations between the three SNPs of the ADM gene and hypertension status were observed. However, SNP rs4399321 was found to be associated with BP levels among the controls. GG homozygotes for this SNP had higher systolic BP (SBP) levels than carriers of the A allele (P ¼ 0.002). Particularly in non-drinkers, GG homozygotes had significantly higher SBP (116.9±0.9 vs. 113.7±0.3 mm Hg, P ¼ 0.001) and diastolic (74.0±0.7 vs. 72.6±0.2 mm Hg, P ¼ 0.046) BP levels than carriers of the A allele. Neither rs4910118 nor rs7944706 was associated with BP levels in the controls either before or after being stratified by drinking status. The results of this study showed that genetic variations in the ADM gene were not associated with the risk of hypertension in a Chinese population. However, the genotype at common variation rs4399321 may influence the BP level in normotensive subjects, especially among non-drinkers. In addition, replications in other populations and further functional studies are required to confirm and interpret the association of ADM with BP.
INTRODUCTION
Hypertension is characterized by a chronic elevation of blood pressure (BP) and affects 26.4% of the world's adult population. 1 Elevated BP has a continuous and graded impact on cardiovascular disease risk and is a major contributor to cardiovascular deaths. 2 Approximately 20-40% of the variation in BP in the general population is determined by genetic factors. 3, 4 Until now, the genetic structure of BP regulation and hypertension has not been fully understood.
Adrenomedullin (ADM), a potent hypotensive peptide consisting of 52 amino-acid residues, was originally isolated from human pheochromocytoma tissue, 5 but it is widely distributed throughout the cardiovascular system. 6, 7 ADM has several potential roles in a variety of cardiovascular pathologies. It causes vasodilatation and increases cardiac output and left ventricular contractility in vivo. 8, 9 The plasma ADM level increases in patients with hypertension, renal failure and congestive heart failure. [10] [11] [12] In healthy volunteers, the infusion of ADM produced significant hemodynamic effects, inhibited aldosterone secretion and activated the sympathetic system. 13 Moreover, midregional proadrenomedullin levels have been recently reported to predict future coronary events in a population-based prospective cohort study. 14 In humans, the ADM gene maps to chromosome 11p15. 4 . A microsatellite marker of cytosine adenine repeats (B5.4 kb downstream of the 3 0 end of the ADM gene) was associated with hypertension in a Japanese population. 15 In another Japanese population, this microsatellite marker and other two single-nucleotide polymorphisms (SNPs), rs4399321 and rs7944706, were not associated with hypertension. 16 SNP -1984 G/A (rs3814700) in the ADM gene was associated with systolic BP (SBP) and pulse pressure in a familybased Chinese population study. 17 These inconsistent findings might result from small sample sizes and limited statistical power. Further studies are necessary to clarify the association between this gene and hypertension. The aim of this study was to investigate the association of genetic variants in the ADM gene with the risk of essential hypertension and with the BP level using a large Chinese Han population sample.
METHODS Subjects
All participants in this study were from the International Collaborative Study of Cardiovascular Disease in Asia (InterASIA in China). 18 InterASIA selected a nationally representative sample of the general population aged 35-74 years in China. A total of 15 838 persons completed the survey and examination. Three BP measurements were obtained from each participant by trained and certified observers according to a standard protocol recommended by the American Heart Association. 19 In this study, hypertensive cases were selected based on an average SBPX150 mm Hg and/or diastolic BP (DBP)X95 mm Hg 20 or the current use of antihypertensive medications. The control subjects had SBPo140 mm Hg, DBPo90 mm Hg and no history of hypertension. Subjects with secondary hypertension, coronary heart disease and diabetes were excluded from this study. The cases and controls were matched for age, gender and area of residence. A total of 4756 subjects (2410 cases and 2346 controls) were included in the current study. Smoking is defined as cigarette consumers who have smoked more than 100 cigarettes. Drinking is defined as alcohol consumers who drank more than 12 times during the year prior to the interview. All subjects were unrelated Han Chinese. Body weight and height were measured twice in light indoor clothing without shoes. Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in meters. The local bioethical committee approved the study protocol, and informed consent was obtained from each participant.
Blood samples were drawn after an overnight fast, and the serum was segregated for biochemical analysis within 2 h. All samples were stored at À70 1C. Serum total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) and glucose were measured on a Hitachi 7060 automatic analyzer (Hitachi, Tokyo, Japan) by enzymatic methods. The concentration of low-density lipoprotein cholestero1 (LDL-C) was calculated by Friedewald's equation for participants who had a TG level o400 mg dl À1 (LDL-C ¼ TC-HDL-C-[TGÄ5]). 21 The Lipid Research Laboratory of the Disease Control and Prevention Center (Atlanta, GA, USA) provided serum for quality controls.
SNP selection and genotyping
Genomic DNA was isolated from peripheral blood leukocytes by the standard method. The ADM gene spans 2.28 kb and comprises four exons and three introns. We searched the HapMap CHB data (http://www.hapmap.org, Rel 27) and selected common SNPs (minor allele frequency 45%) within a 10-kb region spanning the ADM gene (including the 3.86-kb flanking regions each upstream and downstream of the gene). Three tagging SNPs were selected using Haploview software (version 4.2, http://www.broad.mit.edu/mpg/haploview). Sets of tagging SNPs resolving the common haplotypes were selected at an r 2 threshold of 0.8. The SNPs were genotyped by the polymerase chain reaction and restriction fragment length polymorphism method. The following primers were used for genotyping: 5 0 -ATTGGAATGTGAAGAAGTTGA-3 0 and 5 0 -CTGATCCTGGCAATTTATTAAC-3 0 (rs4399321 A4G); 5 0 -GCAGT ACGTGCGGTT TAATAAGT -3 0 and 5 0 -TATGTCCCCTGCCTTTCTAGTC-3 0 (rs4910118 C4T); 5 0 -AGACATGTGCGAGGAGACAGAGA-3 0 and 5 0 -CCCG TGTTTGATTACAAATGTATGGTAGCA-3 0 (rs7944706 G4A), containing one single-base mismatch (underlined). The PCR products for the three polymorphisms were digested overnight at 37 1C with HaeIII, Cfr42I and Mva1269I, followed by detection on 2-3% ethidium bromide-stained agarose gels.
Statistical analysis
The clinical characteristics were compared between hypertensive patients and normotensive subjects. Genetic association analyses were conducted for each of the tagging SNPs in codominant, dominant and recessive models, respectively. Logistic regression analysis was applied to adjust for multiple covariates including age, gender, BMI, smoking and drinking status. The Haplo.score program was used to test for the association of statistically inferred haplotypes with hypertension. 22 It is based on score statistics, which provides both global tests and haplotype-specific tests. Haplo.glm was used to compute the regression of a trait on haplotypes and other covariates. Both Haplo.score and Haplo.glm were implemented in the Haplo.stats software using the R language (http://www.r-project.org). Only the haplotypes with frequencies 41% were considered in the haplotype analyses. The associations between the SNPs and absolute BP levels were tested in the control group and in the hypertensive patients who did not take antihypertensive medications in the past 2 weeks before the study examination. A general linear model was used to adjust for multiple covariates, including age, gender, BMI, smoking and drinking status. Given the fact that environmental factors may modify the effect of genetic factors on BP regulation, we further included the interaction terms of SNPs and smoking or drinking status in the linear models. Descriptive statistical analyses were conducted using SAS software (version 9.1, SAS Institute Inc., Cary, NC, USA). The extent of pairwise linkage disequilibrium between the SNPs and Hardy-Weinberg equilibrium was tested using Haploview software (version 4.2, http://www.broad.mit.edu/mpg/haploview). All statistical tests were two-tailed, and a Po0.05 was considered statistically significant.
RESULTS
The distribution of the clinical and biological characteristics of the cases and controls are given in Table 1 . Compared with the controls, the patients with hypertension had a significantly higher BMI, BP level and serum concentrations of fasting glucose, TG, TC, LDL-C and a lower concentration of HDL-C. The proportions of smokers and drinkers in the patients were similar to those in the control group.
The genotype distribution for each polymorphism was in HardyWeinberg equilibrium. There were no significant differences in the genotypic and allelic distributions for each SNP between the case and control groups (Table 2) . After adjusting for the effects of covariates in the logistic regression model, no association was found between each SNP and hypertension in the codominant, dominant or recessive models (data not shown). There were four major haplotypes with frequencies of 41%, and the haplotype A-C-A was the most common type in this study population (Table 3 ). The haplotype-based test was performed using the Haplo.stats program. In the Haplo.score analysis, the adjusted global score statistic was 3.36 (P ¼ 0.50), which was close to the empirical P-value based on 1000 simulation repetitions (sim-P ¼ 0.33). Compared with the reference haplotype A-C-A, three other haplotypes did not influence the risk of hypertension before or after adjusting for age, gender, BMI, smoking and drinking status.
In addition, we also examined the association between the three SNPs and absolute BP levels using a general linear model in the case and control groups. In the control group, no association was observed between the BP level and SNP rs4910118 or rs7944706. However, for SNP rs4399321, normotensive individuals who were homozygous for the minor G allele had a higher SBP level than the carriers of the A allele (116.3±0.7 vs. 113.9±0.2 mm Hg, P ¼ 0.002). Further analyses revealed that there might be an interactive effect of SNP rs4399321 and drinking status on the DBP (P ¼ 0.041), but not the SBP (P ¼ 0.137) level in controls. We further conducted stratified analyses according to drinking status (Figure 1 ). In normotensive nondrinkers, we observed that the subjects homozygous for the minor G allele had a significantly higher SBP (116.9±0.9 vs. 113.7±0.3 mm Hg, P ¼ 0.001) and DBP (74.0 ± 0.7 vs. 72.6 ± 0.2 mm Hg, P ¼ 0.046) than the carriers of the A allele. There was no association between rs4399321 and BP levels in normotensive drinkers. In addition, we did not observe any significant association between these SNPs and BP levels in the hypertensive patients who were not taking antihypertensive medications.
DISCUSSION
Essential hypertension is a multifactorial disorder that involves the additive effects of many genes, each of which has a moderate effect on the development of hypertension. 23 These genetic determinants interact with environmental factors to produce the final disease phenotype. SNPs can confer a genetic predisposition toward various complex diseases. In this large case-control study, we investigated whether ADM gene variations were associated with hypertension and BP levels in a Chinese Han population. We found a significant association between SNP rs4399321 and BP level in the control subjects, particularly in non-drinkers. Vascular cells, such as endothelial cells and smooth muscle cells, can produce and secrete ADM. 24, 25 ADM is a strong vasodilatory peptide that has a wide range of biological actions related to vascular functions. In humans, ADM can reduce total peripheral resistance, lowering BP level and increasing heart rate. 26 ADM exerts its biological activity by combining with specific receptor complexes composed of the calcitonin receptor-like receptor and receptoractivity modifying proteins (RAMP), which has three subtypes (RAMP1-3). ADM modulates BP through both central 27 and peripheral 28 mechanisms. ADM has been reported to induce nitric oxide production by activating phosphatidylinositol 3-kinase and Akt via the Ca 2 þ /calmodulin-dependent pathway, which then induces endothelium-dependent vasodilation. 29 There was a significant correlation independent of age and BP between the plasma ADM level and pulse wave velocity. 30 Plasma levels of ADM are correlated with BP increases in hypertensive patients and thus with disease severity. 31 ADM inhibits hypertrophy in cultured cardiomyocytes. 32 In a Japanese study, there was no association of rs4399321 or rs7944706 of the ADM gene with hypertension. 16 In a small, familybased Chinese population study, SNP rs3814700 of the ADM gene is associated with SBP and sodium excretion. 17 In this study, we did not examine rs3814700 directly, but we genotyped one of its proxy SNPs, rs4399321. The r 2 between these two SNPs is 0.94 in the HapMap Chinese (CHB) population (Figure 2) . We found an association between rs4399321 and BP level in this studied population.
The results of this study indicate an interaction between rs4399321 and drinking status on the BP level. Among non-drinkers, GG homozygotes had higher BP levels than A allele carriers. These results indicated that the G allele might have different roles in BP regulation according to the absence or presence of alcohol drinking. In rats, chronic ethanol intake increased the mRNA levels of pre-pro-ADM and reduced ADM-induced relaxation in the vasculature. 33, 34 Because of the protective and beneficial role of ADM on the cardiovascular system, increased ADM expression could act as a compensatory response to cardiovascular injuries or dysfunction induced by ethanol. In fact, ethanol altered mRNA expression by activating different pathways and was associated with both increases and decreases in mRNA levels. 35 In addition, the effect of ethanol on the cardiovascular system is dose-dependent. 36 Thus, the discrepancies observed for alcohol drinking may mask the influence of individual variants of this polymorphism in our study population. Our results provide evidence for an interactive effect between one common SNP in the ADM gene and alcohol drinking on BP, with a demonstrable difference in the individual SNP effects according to drinking status. The specific mechanism underlying this interaction is unknown, and further studies are warranted.
To speculate on the possible function of SNP rs4399321, we investigated its structure using TESS (http://www.cbil.upenn.edu/ cgi-bin/tess/tess), a web tool for predicting transcription element binding sites in DNA sequences. The TESS analysis showed that rs4399321 lies in a recognition sequence of the transcription element retinoic acid receptor-g and may alter transcription of the ADM gene. Retinoic acid receptor can activate transcription by binding to retinoic acid-response elements in the promoters of primary target genes. This analysis suggests that SNP rs4399321 may act as a transcriptional regulatory factor contributing to the development and occurrence of essential hypertension. Thus, functional studies to determine whether this SNP regulates the transcription of the ADM gene are warranted. Certainly, we still cannot exclude the possibility that this SNP is in strong linkage disequilibrium with the true functional variation, which was not analyzed in the current study. The major limitation of our study is that we did not examine the plasma concentration of ADM in participants. A recent study showed that SNP rs4910118 was independently associated with the plasma ADM level. 37 Thus, we may not estimate the effect of these genetic variations on the plasma level of ADM and not detect their true effects on essential hypertension. Second, although rs4399321 was associated with the BP level, we failed to observe the association of this SNP with hypertension. In addition, we did not observe any significant associations between rs4399321 and BP levels in the cases. This negative finding may be due to the decreased power caused by excluding the patients who were treated with antihypertensive medications. Future studies with larger sample sizes are warranted to clarify the actual role of this SNP in BP regulation. However, this study also has two important strengths. First, in addition to the large sample size and ethnically homogeneous study population, tagging SNPs with relatively high minor allele frequency were selected to further increase the power to detect modest effect sizes. Second, we identified an interaction between the ADM gene and alcohol drinking in the regulation of BP.
In summary, our study suggests that genetic variation in the ADM gene may influence the BP level in a Chinese Han population. Furthermore, this study provided evidence that interactions between ADM genotype and drinking status influenced BP levels. These findings will potentially contribute to a better understanding of the mechanism of BP control. In addition, independent replications of these findings and further functional investigations are warranted in the future.
